Hanall Biopharma Co (XKRX:009420) Other Current Receivables : ₩6,894 Mil (As of Dec. 2023)

View and export this data going back to 1989. Start your Free Trial

What is Hanall Biopharma Co Other Current Receivables?

Hanall Biopharma Co's Other Current Receivables for the quarter that ended in Dec. 2023 was ₩6,894 Mil.

Hanall Biopharma Co's quarterly Other Current Receivables declined from Jun. 2023 (₩9,200.14 Mil) to Sep. 2023 (₩6,499.61 Mil) but then increased from Sep. 2023 (₩6,499.61 Mil) to Dec. 2023 (₩6,893.93 Mil).

Hanall Biopharma Co's annual Other Current Receivables declined from Dec. 2021 (₩6,999.44 Mil) to Dec. 2022 (₩4,020.56 Mil) but then increased from Dec. 2022 (₩4,020.56 Mil) to Dec. 2023 (₩6,893.93 Mil).

Hanall Biopharma Co Other Current Receivables Historical Data

The historical data trend for Hanall Biopharma Co's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanall Biopharma Co Other Current Receivables Chart

Hanall Biopharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Receivables

Get a 7-Day Free Trial

8,420.62

5,685.76

6,999.44

4,020.56

6,893.93

Hanall Biopharma Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Current Receivables	Get a 7-Day Free Trial															4,020.56	6,499.70	9,200.14	6,499.61	6,893.93

Hanall Biopharma Co Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Hanall Biopharma Co Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Hanall Biopharma Co's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Hanall Biopharma Co (XKRX:009420) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanall Biopharma Co Ltd (XKRX:009420) » Definitions » Other Current Receivables

Traded in Other Exchanges

N/A

Address

12 Bongeunsa-ro 114-gil, Daewoong Building, 3rd Floor, Gangnam-gu, Seoul, KOR

Website

http://www.hanall.co.kr

Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.

Hanall Biopharma Co (XKRX:009420) Headlines

No Headlines